3649 results for «635»

Filter By

3649 results

EuroPCR 2018 Opening Ceremony and Ethica Awards

22 May 2018 – From EuroPCR 2018

Join J. Fajadet and W. Wijns for the EuroPCR 2018 Opening Ceremony and find out who this year's Ethica Awards winners are!

EuroPCR 2018 Opening Ceremony and Ethica Awards

EuroPCR 2018 Closing Ceremony

25 May 2018 – From EuroPCR 2018

Consult the session video on the Closing Ceremony of EuroPCR 2018 presented by A. Baumbach.

EuroPCR 2018 Closing

Nurses and Allied Professionals Best Abstract and Clinical Case Awards and Closing Ceremony

24 May 2018 – From EuroPCR 2018

Consult this session to see best abstract and clinical case awards for nurses and allied professionals at EuroPCR 2018.

Nurses and Allied Professionals Best Abstract and Clinical Case Awards and Closing Ceremony

Rapid fire session on next generation structural heart and valve therapies

18 May 2026 – From EuroPCR 2026

An intensive rapid-fire session presenting the latest advancements in next-generation structural heart and valve therapies, including novel transcatheter systems for aortic and mitral valve repair, innovative solutions for tricuspid regurgitation, and implant-free PFO closure technologies.

Routine cerebral embolic protection in transcatheter aortic valve implantation: the British Heart Foundation (BHF) PROTECT-TAVI trial

29 Mar 2025

Aaysha Cader and Ali Nazmi Calik provide their take on the BHF PROTECT-TAVI trial, presented by Rajesh Kharbanda at ACC.25 in Chicago.

Author

Aaysha Cader
Ali Nazmi Calik

Author

Ali Nazmi Calik
Routine cerebral embolic protection in TAVI: the British Heart Foundation (BHF) PROTECT-TAVI trial

EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...

EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

FAVOR III China: Angiographic quantitative flow ratio-guided coronary intervention - a multicentre, randomised, sham-controlled trial

04 Nov 2021

Nicola Ryan provides her take on this investigator initiated, multicentre, randomised, blinded, sham controlled trial compares clinical outcomes of QFR versus angiography guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina or MI at least 72 hours prior to screening....

Nicola Ryan

Author

Nicola Ryan
FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI

How to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in TAVI

29 Jan 2026

Large-bore femoral access closure remains a critical step in transfemoral TAVI, where access-site complications can significantly impact outcomes.

This My Toolkit article presents a step-by-step tutorial on a combined suture- and plug-based closure strategy using one ProStyle™ and one Angio-Seal®. The technique aims to achieve rapid, reliable...

Akiko Masumoto

Author

Akiko Masumoto

Author

Chiara De Biase
How to close vascular access with a combined suture-/plug-based strategy using one ProStyle and one Angio-Seal in TAVI
Didn’t find what you were looking for?